Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy Stifel Nicolaus

Galmed Pharmaceuticals Ltd.
Start price
€6.40
21.02.25 / 50%
Target price
€89.66
21.02.26
Performance (%)
-
End price
-
22.02.26
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Galmed Pharmaceuticals Ltd. - - -
iShares Core DAX® 3,59 % 6,43 % 15,38 %
iShares Nasdaq 100 5,81 % 6,38 % 41,46 %
iShares Nikkei 225® 4,08 % 9,31 % 48,95 %
iShares S&P 500 4,14 % 4,94 % 31,59 %

Comments by Stifel_Nicolaus for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) -
Target price 89.657
Change
Ends at 21.02.26

Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Stifel Nicolaus from $92.00 to $94.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat

Stifel Nicolaus 
0
Report Share
21.02.25
In the thread Trading Galmed Pharmaceuticals Ltd.
Prediction Buy
Perf. (%) -
Target price 89.657
Change
Ends at 21.02.26

Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten

Stifel Nicolaus 
0
Report Share
22.02.26

Stopped prediction by Stifel_Nicolaus for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
06.11.24
€85.67
06.11.25
-
07.11.25

Stifel Nicolaus 
06.11.24 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€0.38
08.05.24
€65.08
08.05.25
1602.13%
09.05.25

Stifel Nicolaus 
08.05.24 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€0.34
21.02.24
€59.19
21.02.25
1782.35%
22.02.25

Stifel Nicolaus 
21.02.24 50%